As per DelveInsight's Retinitis pigmentosa, epidemiological model, the diagnosed Retinitis Pigmentosa prevalent population in the 7MM (the US, EU5 and Japan) was observed to be 253,420 in 2017.
DelveInsight's 'Retinitis Pigmentosa Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Retinitis Pigmentosa epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Geographies Covered
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Study Period: 2017-2030
Click to Know More about the Report.
Disease Overview
Retinitis pigmentosa is a heterogeneous, progressive disease that leads to worsening of the vision with time.
Although, there is a significant variation in the age of onset, progression rate, the involvement of rod, and cone, retinal cells deterioration, however; the clinical manifestations that are kept in mind while diagnosing are night blindness, progressive loss of peripheral vision and subsequent loss of central vision.
Retinitis Pigmentosa Epidemiology
The DelveInsight Retinitis Pigmentosa epidemiology report gives a thorough understanding of the Retinitis Pigmentosa by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Retinitis Pigmentosa in the US, Europe, and Japan. The report covers the detailed information of the Retinitis Pigmentosa epidemiology scenario in seven major countries (US, EU5, and Japan).
Being a rare disease, gathering and evaluating Retinitis Pigmentosa epidemiological data is rather a challenging task, and the data is often available in fragments and partial form.
As per DelveInsight’s Retinitis pigmentosa, epidemiological model, the diagnosed Retinitis Pigmentosa prevalent population in the 7MM (the US, EU5 and Japan) was observed to be 253,420 in 2017.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology:
- Total Diagnosed Prevalent Cases of Retinitis Pigmentosa,
- Gender-Specific Diagnosed Prevalence of Retinitis Pigmentosa,
- Type-Specific Diagnosed Prevalence of Retinitis Pigmentosa,
- Subtype-Specific Diagnosed Prevalence of Syndromic and Systemic RP, and
- Subtype-specific Diagnosed Prevalent Cases of Non-Syndromic RP in the 7MM) scenario of Retinitis Pigmentosa
Table of Contents
1. Key Insights
2. Executive Summary of Retinitis Pigmentosa (RP)
3. Retinitis Pigmentosa: Disease Background and Overview
4. Case Reports
5. Epidemiology and Patient Population
6. United States Epidemiology
7. EU5 Epidemiology
8. Japan Epidemiology
9. SWOT Analysis
10. Appendix
11. DelveInsight Capabilities
12. Disclaimer
About DelveInsight
DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for better growth in the market.
Browse through our vast repository
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Vinita Rakheja
Email:Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: www.delveinsight.com/
